。$四季教育(FEDU)$ $华富教育(WAFU)$查看全文
智通财经APP讯,先声药业(02096)发布公告,该公司与Kazia Therapeutics Limited(Kazia)合作的创新药SIM0395(Paxalisib)于2021年12月6日获得中国国家药品监督管理局签发的药物临床试验批准通知书,拟用于胶质母细胞瘤(GBM),包括新诊断和... 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-285196 Act: 34 Size: 36 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-285170 Act: 34 Size: 953 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-281488 Act: 34 Size: 70 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-280704 Act: 34 Size: 18 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-277577 Act: 34 Size: 44 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-276668 Act: 34 Size: 40 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-268217 Act: 34 Size: 33 KB 网页链接
$Kazia Therapeutics(KZIA)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001193125-23-263551 Act: 34 Size: 13 MB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-260390 Act: 34 Size: 43 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-256085 Act: 34 Size: 74 KB 网页链接